Skip to main content

Animations

MJFF Publications

5861 - 5870 of 9145 Results
Title
Year
  • Year
  • 2017
  • 2011
  • 2010
  • 2012
  • 2013
  • 2015
  • 2014
  • 2009
  • 2007
  • 2012
  • Summary Details
    OPEN
    Title: Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-017-07181-0
    Citation Count: 157
  • Summary Details
    OPEN
    Title: Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.12.032
    Citation Count: 72
  • Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
    2010
    Summary Details
    OPEN
    Title: Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2010.12.008
    Citation Count: 187
  • Summary Details
    OPEN
    Title: Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders
    Journal Name: Occupational and Environmental Medicine
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/oemed-2011-100119
    Citation Count: 112
  • Summary Details
    OPEN
    Title: α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.03.038
    Citation Count: 43
  • Summary Details
    OPEN
    Title: M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2015.10.039
    Citation Count: 249
  • Summary Details
    OPEN
    Title: Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson Disease
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2014.08.061
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2009.01.020
    Citation Count: 45
  • Summary Details
    RESTRICTED
    Title: Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide
    Journal Name: Neurochemistry International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuint.2006.12.013
    Citation Count: 86
  • Summary Details
    OPEN
    Title: Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations
    Journal Name: Neurochemistry International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuint.2012.12.001
    Citation Count: 67
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.